Lord, Abbett & Co. LLC Arcellx, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 891,848 shares of ACLX stock, worth $86.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
891,848
Previous 873,844 2.06%
Holding current value
$86.4 Million
Previous $48.2 Million 54.43%
% of portfolio
0.24%
Previous 0.16%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$50.91 - $86.61 $916,583 - $1.56 Million
18,004 Added 2.06%
891,848 $74.5 Million
Q2 2024

Oct 07, 2024
SELL
$49.74 - $66.98 $16.1 Million - $21.7 Million
-324,273 Reduced 27.07%
873,844 $48.2 Million
Q2 2024

Aug 14, 2024
SELL
$49.74 - $66.98 $16.1 Million - $21.7 Million
-324,273 Reduced 27.07%
873,844 $48.2 Million
Q1 2024

Oct 07, 2024
BUY
$51.85 - $73.49 $80,367 - $113,909
1,550 Added 0.13%
1,198,117 $83.3 Million
Q1 2024

May 09, 2024
BUY
$51.85 - $73.49 $80,367 - $113,909
1,550 Added 0.13%
1,198,117 $83.3 Million
Q4 2023

Oct 07, 2024
BUY
$31.75 - $57.99 $3.13 Million - $5.71 Million
98,530 Added 8.97%
1,196,567 $66.4 Million
Q4 2023

Feb 12, 2024
BUY
$31.75 - $57.99 $3.13 Million - $5.71 Million
98,530 Added 8.97%
1,196,567 $66.4 Million
Q3 2023

Oct 07, 2024
SELL
$31.51 - $37.4 $5.27 Million - $6.26 Million
-167,335 Reduced 13.22%
1,098,037 $39.4 Million
Q3 2023

Nov 13, 2023
SELL
$31.51 - $37.4 $5.27 Million - $6.26 Million
-167,335 Reduced 13.22%
1,098,037 $39.4 Million
Q2 2023

Oct 07, 2024
BUY
$27.49 - $46.9 $5.31 Million - $9.06 Million
193,165 Added 18.02%
1,265,372 $40 Million
Q2 2023

Aug 14, 2023
BUY
$27.49 - $46.9 $5.31 Million - $9.06 Million
193,165 Added 18.02%
1,265,372 $40 Million
Q1 2023

Oct 07, 2024
BUY
$26.92 - $33.94 $14.1 Million - $17.8 Million
523,710 Added 95.48%
1,072,207 $33 Million
Q1 2023

May 12, 2023
BUY
$26.92 - $33.94 $14.1 Million - $17.8 Million
523,710 Added 95.48%
1,072,207 $33 Million
Q4 2022

Oct 07, 2024
SELL
$17.18 - $33.0 $5.59 Million - $10.7 Million
-325,347 Reduced 37.23%
548,497 $17 Million
Q4 2022

Feb 10, 2023
SELL
$17.18 - $33.0 $1.61 Million - $3.09 Million
-93,659 Reduced 14.59%
548,497 $17 Million
Q3 2022

Nov 14, 2022
BUY
$16.67 - $22.04 $2.25 Million - $2.98 Million
135,162 Added 26.66%
642,156 $12.1 Million
Q2 2022

Aug 12, 2022
BUY
$7.21 - $24.43 $3.66 Million - $12.4 Million
506,994 New
506,994 $9.17 Million

Others Institutions Holding ACLX

# of Institutions
201
Shares Held
44.1M
Call Options Held
2.1M
Put Options Held
778K
View Full List

About Arcellx, Inc.

ACLX Quotes by TradingView
  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $4.25B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email